Clinical impact of metformin exposure during Staphylococcus aureus bacteremia in patients with diabetes mellitus
ConclusionsMetformin exposure during SAB appears to be an independent predictor of survival in patients with diabetes.
Source: European Journal of Clinical Microbiology and Infectious Diseases - Category: Microbiology Source Type: research
More News: Diabetes | Diabetes Mellitus | Endocrinology | Fortamet | Infectious Diseases | Metformin | Microbiology | Staphylococcus Aureus | Study